1062205-33-7

Basic information

• Product Name: 3-[9-(1-{[4-(dimethylamino)-1-naphthyl]methyl}piperidin-4-yl)-6-morpholin-4-yl-9H-purin-2-yl]phenol
• Synonyms: 3-[9-(1-{[4-(dimethylamino)-1-naphthyl]methyl}piperidin-4-yl)-6-morpholin-4-yl-9H-purin-2-yl]phenol
• CAS NO: 1062205-33-7
• Molecular Weight: 563.702
• Mol File: 1062205-33-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[9-(1-{[4-(dimethylamino)-1-naphthyl]methyl}piperidin-4-yl)-6-morpholin-4-yl-9H-purin-2-yl]phenol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[9-(1-{[4-(dimethylamino)-1-naphthyl]methyl}piperidin-4-yl)-6-morpholin-4-yl-9H-purin-2-yl]phenol(1062205-33-7)
• EPA Substance Registry System: 3-[9-(1-{[4-(dimethylamino)-1-naphthyl]methyl}piperidin-4-yl)-6-morpholin-4-yl-9H-purin-2-yl]phenol(1062205-33-7)

Safety Data

• Hazardous Substances Data: 1062205-33-7(Hazardous Substances Data)

Upstream product

• 1062205-68-8 3-(6-morpholin-4-yl-9-piperidin-4-yl-9H-purin-2-yl)phenol 
• 1971-81-9 4-dimethylamino-1-naphthaldehyde 

Relevant articles and documents

IMIDAZOLOPYRIMIDINE ANALOGS AND THEIR USE AS PI3 KINASE AND MTOR INHIBITORS

The present invention relates to Imidazolopyrimidine Analogs, methods of making Imidazolopyrimidine Analogs, compositions comprising an Imidazolopyrimidine Analog, and methods for treating or preventing a PI3K-related disorder comprising administering to a subject in need thereof an effective amount of an Imidazolopyrimidine Analog. The invention also relates to methods for treating or preventing mTOR-related disorders comprising administering to a subject in need thereof an effective amount of an Imidazolopyrimidine Analog.